Skip to main content

Table 2 Multivariable regression analysis on the association between dietary niacin intake and BPH risk, weighted

From: Association between dietary niacin intake and benign prostatic hyperplasia: a population-based results from NHANES 2003–2008

Exposure

OR (95%CI), P value

Model 1

Model 2

Model 3

Dietary niacin

1.05(1.01,1.09)

0.01

1.04(1.01,1.07)

0.02

1.04(1.01, 1.07)

0.02

Dietary niacin categories

T1

Reference

Reference

Reference

T2

3.25(1.60,6.61)

0.002

2.77(1.34, 5.73)

0.01

2.91(1.38, 6.15)

0.01

T3

2.83(1.29,6.23)

0.01

2.22(1.16, 4.28)

0.02

2.34(1.24, 4.42)

0.01

P for trend

0.017

0.024

0.015

  1. BPH: Benign Prostatic Hyperplasia; PIR: Poverty-to-Income Ratio; CVD: Cardiovascular Diseases. OR: odds ratio; CI: confidence interval; T: Tertile
  2. Model 1: unadjusted;
  3. Model 3: adjusted for age, race, marital status, education level, and PIR;
  4. Model 3: additionally adjusted for BMI, smoking status, alcohol consumption, diabetes mellitus, hypertension, and CVD